Trial intelligence / Profile preview

Simethicone and Multilac Baby in Infantile Colic

NCT04666324Unknown

Start
Dec 2020
Primary completion
Jun 2021
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

Randomised, open-label trial of Multilac Baby in infantile colic (2 arms). Primary endpoints: Change of days of crying at 3 weeks, Change of average duration of evening crying at 3 weeks and 1 more. Status: unknown.

02

Drugs

Multilac Baby
03

Conditions

infantile colic

Beyond the preview

Go deeper on NCT04666324.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04666324.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call